Multidisciplinary research projects on personalised medicine – prevention in personalised medicine
AIMS OF THE CALL
With its fifth transnational call (non-cofunded by the EC), ERA PerMed aims to foster research in prevention in personalised medicine. The overarching goal of the call is the development of tailor-made strategies for prevention of disease and disease progression, at three different levels:
- preventive measures decreasing the rate of incidence (primary prevention),
- early detection to increase the efficacy of a preventive therapy, even before symptoms are developed (secondary prevention), and
- interventions preventing disease recurrence or improving patients’ care and quality of life (tertiary prevention).
Research on prevention from over-treatment or overmedicalisation in primary, secondary and tertiary personalised preventive approaches is optional and could be part of research proposals, if applicable.
The clinical relevance of the proposed PM approach needs to be convincingly demonstrated.
The overall objectives of the ERA PerMed call are to:
- Support translational research projects in the field of personalised medicine;
- Encourage and enable interdisciplinary collaborations towards implementation of PM, in combining pre-clinical or clinical research with bio-informatics components as well as ELSA research or implementation research, including health economics;
- Encourage collaboration between academia (research teams from universities, higher education institutions, public research institutions, research centres), clinical/public health research (research teams from hospital/ public health, healthcare settings and other healthcare organisations), private partners e.g. SMEs (small and medium-sized enterprises) as well as policy makers, regulatory/HTA agencies and patient organisations.
Scope of the call
The JTC2022 is constructed around the following three research areas in order to ensure the development of specific PM approaches considering the major aspects needed for their successful implementation in the health systems: (1) “Translating Basic to Clinical Research and Beyond”, (2) “Data and Information and Communication Technology (ICT)” and (3) “Responsible and Effective Implementation in Healthcare”.
Each proposal MUST address at least one module out of each research area:
Topic of ICPerMed Partnering tool
If you are looking for potential partners, please have a look also at the ICPerMed Partnering Tool for Personalised Medicine Research. To access it, please follow this link.
The ICPerMed Partnering Tool facilitates networking among universities, clinical sector, research and patient organisations, SMEs, industry and all other stakeholders interested in personalised medicine. The tool enables users to present their expertise to the personalised medicine research community and to search for partners. By completing and activating the profile, it becomes available to all users. The partner search function is available for all users, also for those who do not publish their partnering profile. The tool assists users in finding suitable cooperation partners. The tool might be of particular help for applicants coming from countries that joined ERA PerMed calls recently.
Eligibility
At least one Danish non-academia institution as co-applicant in the transnational consortium.
Read about the Danish Rules and Guidelines for international projects
GENERAL (eligibility) CONDITIONS FOR APPLICATION
Joint research proposals may be submitted by applicants belonging to the following categories (subject to regional/national funding regulations):
- Academia (research teams working in universities, other higher education institutions) or research institutes;
- Clinical/public health sector (research teams working in hospitals/public health and/or other healthcare settings and health organisations). Participation of clinicians (e.g. medical doctors, nurses) in the research teams is encouraged;
- Private for-profit (industry) partners, e.g. SME (small and medium-sized enterprises) and private non-profit partners, e.g. foundations, associations or non-governmental organisations.
Participating funding organisations clarify the national and regional funding possibilities in detail in the published Call Text and Guidelines for Applicants.
